BRIEF published on 10/03/2024 at 18:35, 2 years ago Poxel announces its financial and strategic results for 2023 Financial Results Biopharmaceutical TWYMEEG® Poxel OrbiMed
PRESS RELEASE published on 10/03/2024 at 18:30, 2 years ago Informations privilégiées / Communiqué sur comptes, résultats Poxel publie ses résultats financiers pour l'année 2023 et dresse un bilan de ses activités. Accord avec OrbiMed, webinaires de présentation et perspectives de croissance Résultats Financiers Croissance Webinaires Poxel OrbiMed
BRIEF published on 09/30/2024 at 07:35, 2 years 1 month ago Poxel Secures $50M Non-Dilutive Financing from OrbiMed Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
BRIEF published on 09/30/2024 at 07:35, 2 years 1 month ago Poxel obtient un financement non dilutif de 50 millions de dollars auprès d'OrbiMed Financement Non Dilutif TWYMEEG® Poxel Monétisation Des Redevances OrbiMed
PRESS RELEASE published on 09/30/2024 at 07:30, 2 years 1 month ago Inside Information / Other news releases Poxel monetizes TWYMEEG® royalties in a USD 50 million deal with OrbiMed. Proceeds to reduce debt and support rare disease activities. Webinars scheduled for investor updates Webinars Royalties TWYMEEG® Poxel OrbiMed
BRIEF published on 09/09/2024 at 07:35, 2 years 1 month ago POXEL annonce une hausse significative de ses ventes au deuxième trimestre 2024 Partenariats Trésorerie Ventes TWYMEEG® Poxel
BRIEF published on 09/09/2024 at 07:35, 2 years 1 month ago POXEL announces a significant increase in its sales in the second quarter of 2024 Sales Treasury Partnerships TWYMEEG® Poxel
PRESS RELEASE published on 09/09/2024 at 07:30, 2 years 1 month ago Informations privilégiées / Autres communiqués Poxel annonce ses chiffres pour le T2 et S1 2024, avec hausse des ventes de TWYMEEG® au Japon et bilan des activités. Discussions en cours pour monétisation des redevances et horizon financier solide Chiffre D'affaires Japon Poxel TWYMEEG Redevances
BRIEF published on 08/16/2024 at 08:16, 2 years 2 months ago Poxel : Évolution du Capital Social et du Nombre de Droits de Vote Droits De Vote Capital Social Actions AMF Poxel
BRIEF published on 08/16/2024 at 08:16, 2 years 2 months ago Poxel: Evolution of the Share Capital and the Number of Voting Rights Share Capital Voting Rights Actions AMF Poxel
Published on 10/30/2026 at 23:35, 14 hours 3 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 14 hours 8 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 16 hours 51 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 18 hours 38 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 22 hours 8 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 22:49, 14 hours 49 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 19 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 14 hours 38 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 14 hours 38 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
